{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:18:01Z","timestamp":1778861881866,"version":"3.51.4"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02235-0","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:20:20Z","timestamp":1776727220000},"page":"2873-2888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review"],"prefix":"10.1007","volume":"34","author":[{"given":"Sumel","family":"Ashique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohini","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Sadique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabarak","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juberahamad Rajjak","family":"Attar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Yousuf","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"325","key":"2235_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2021.1658","volume":"16","author":"EH Adhikari","year":"2021","unstructured":"Adhikari EH, Spong CY (2021) COVID-19 vaccination in pregnant and lactating women. JAMA 16(325):1039","journal-title":"JAMA"},{"key":"2235_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2023.04.001","volume":"70","author":"H Akbari","year":"2023","unstructured":"Akbari H, Taghizadeh-Hesary F (2023) COVID-19 induced liver injury from a new perspective: mitochondria. Mitochondrion 70:103\u2013110","journal-title":"Mitochondrion"},{"key":"2235_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1056\/NEJMc2103825","volume":"385","author":"G Anichini","year":"2021","unstructured":"Anichini G, Terrosi C, Gandolfo C, GoriSavellini G, Fabrizi S, Miceli GB et al (2021) COVID-19 antibody response in persons with past natural infection. N Engl J Med 385:90\u201392","journal-title":"New Engl J Med"},{"key":"2235_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.22207\/JPAM.14.3.01","volume":"14","author":"VA Arumugam","year":"2020","unstructured":"Arumugam VA, Thangavelu S, Fathah Z, Ravindran P, Sanjeev AMA, Babu S et al (2020) COVID-19 and the world with co-morbidities of heart disease, hypertension and diabetes. J Pure Appl Microbiol 14:1623\u20131638","journal-title":"J Pure Appl Microbiol"},{"key":"2235_CR5","doi-asserted-by":"crossref","unstructured":"Atyeo C, DeRiso EA, Davis C, Bordt EA, DeGuzman RM, Shook LL et al (2021) COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women. bioRxiv","DOI":"10.1101\/2021.04.04.438404"},{"key":"2235_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069741","author":"ML Badell","year":"2022","unstructured":"Badell ML, Dude CM, Rasmussen SA, Jamieson DJ (2022) COVID-19 vaccination in pregnancy. BMJ. https:\/\/doi.org\/10.1136\/bmj-2021-069741","journal-title":"BMJ"},{"issue":"204","key":"2235_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4049\/jimmunol.1900888","volume":"1950","author":"KJ Baines","year":"2020","unstructured":"Baines KJ, Rampersaud AM, Hillier DM, Jeyarajah MJ, Grafham GK, Eastabrook G et al (2020) Antiviral inflammation during early pregnancy reduces placental and fetal growth trajectories. J Immunol 1950(204):694\u2013706","journal-title":"J Immunol"},{"issue":"3","key":"2235_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/08903344211030168","volume":"37","author":"JK Baird","year":"2021","unstructured":"Baird JK, Jensen SM, Urba WJ, Fox BA, Baird JR (2021) SARS-CoV-2 antibodies detected in mother\u2019s milk post-vaccination. J Hum Lact 37(3):492\u2013498","journal-title":"J Hum Lact"},{"key":"2235_CR9","doi-asserted-by":"publisher","first-page":"e150319","DOI":"10.1172\/JCI150319","volume":"131","author":"O Beharier","year":"2021","unstructured":"Beharier O, Plitman Mayo R, Raz T, Nahum Sacks K, Schreiber L, Suissa-Cohen Y et al (2021) Efficient maternal to neonatal transfer of antibodies against COVID-19 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest 131:e150319","journal-title":"J Clin Invest"},{"key":"2235_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.vaccine.2020.12.074","volume":"39","author":"RH Beigi","year":"2021","unstructured":"Beigi RH, Krubiner C, Jamieson DJ, Lyerly AD, Hughes B, Riley L et al (2021) The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine 39:868","journal-title":"Vaccine"},{"key":"2235_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jad.2015.11.014","volume":"191","author":"A Biaggi","year":"2016","unstructured":"Biaggi A, Conroy S, Pawlby S, Pariante CM (2016) Identifying the women at risk of antenatal anxiety and depression: a systematic review. J Affect Disord 191:62\u201377","journal-title":"J Affect Disord"},{"key":"2235_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1001\/jama.2021.1865","volume":"325","author":"DW Bianchi","year":"2021","unstructured":"Bianchi DW, Kaeser L, Cernich AN (2021) Involving pregnant individuals in clinical research on COVID-19 vaccines. JAMA 325:1041\u20131042","journal-title":"JAMA"},{"key":"2235_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ajog.2021.08.007","volume":"226","author":"H Blakeway","year":"2022","unstructured":"Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K et al (2022) COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol 226:236-e1","journal-title":"Am J Obstet Gynecol"},{"key":"2235_CR14","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/s41390-022-02360-w","volume":"93","author":"L Bode","year":"2022","unstructured":"Bode L, Bertrand K, Najera JA, Furst A, Honerkamp\u2010Smith G, Shandling AD et al (2022) Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection. Pediatr Res 93:1626\u201333","journal-title":"Pediatr Res"},{"key":"2235_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","volume":"103","author":"CJ Bowman","year":"2021","unstructured":"Bowman CJ, Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW et al (2021) Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol 103:28\u201335","journal-title":"Reprod Toxicol"},{"key":"2235_CR16","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1080\/14767058.2021.1920916","volume":"35","author":"E Brillo","year":"2022","unstructured":"Brillo E, Tosto V, Gerli S, Buonomo E (2022) COVID-19 vaccination in pregnancy and postpartum. J Matern Fetal Neonatal Med 35:6727\u201346","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2235_CR17","doi-asserted-by":"publisher","first-page":"744104","DOI":"10.3389\/fped.2021.744104","volume":"9","author":"A Camacho-Morales","year":"2021","unstructured":"Camacho-Morales A, Caba M, Garc\u00eda-Ju\u00e1rez M, Caba-Flores MD, Viveros-Contreras R, Mart\u00ednez-Valenzuela C (2021) Breastfeeding contributes to physiological immune programming in the newborn. Front Pediatr 9:744104","journal-title":"Front Pediatr"},{"key":"2235_CR18","unstructured":"Canada (2025) PHA of. summary: guidance on the use of COVID-19 vaccines for 2025 to summer 2026. [cited 2025 Jul 7]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-summary-guidance-covid-19-vaccines-2025-summer-2026.html"},{"key":"2235_CR19","unstructured":"CDC (2025) Vaccine safety. [cited 2025 Jul 6]. Coronavirus disease 2019 (COVID-19) vaccine safety. Available from: https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/covid-19.html"},{"issue":"13","key":"2235_CR20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2020.15580","volume":"324","author":"CD Chambers","year":"2020","unstructured":"Chambers CD, Krogstad PA, Bertrand K, Contreras DA, Tobin NH, Bode L et al (2020) Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 324(13):1347\u20131348","journal-title":"JAMA"},{"key":"2235_CR21","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.vaccine.2021.02.007","volume":"39","author":"L Chu","year":"2021","unstructured":"Chu L, McPhee R, Huang W, Bennett H, Pajon R, Nestorova B et al (2021) A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 COVID-19 vaccine. Vaccine 39:2791\u20139","journal-title":"Vaccine"},{"key":"2235_CR22","doi-asserted-by":"publisher","first-page":"e0257930","DOI":"10.1371\/journal.pone.0257930","volume":"17","author":"NM Clark","year":"2022","unstructured":"Clark NM, Janaka SK, Hartman W, Stramer S, Goodhue E, Weiss J et al (2022) Anti-COVID-19 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection. PLoS ONE 17:e0257930","journal-title":"PLoS ONE"},{"key":"2235_CR23","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.2021.7563","volume":"325","author":"ARY Collier","year":"2021","unstructured":"Collier ARY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J et al (2021) Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA 325:2370\u201380","journal-title":"JAMA"},{"key":"2235_CR24","doi-asserted-by":"publisher","first-page":"e2020031690","DOI":"10.1542\/peds.2020-031690","volume":"147","author":"C Conzelmann","year":"2020","unstructured":"Conzelmann C, Gross R, Meister TL, Todt D, Krawczyk A, Dittmer U et al (2020) pasteurization Inactivates SARS-CoV-2\u2013spiked breast milk. Pediatrics 147:e2020031690","journal-title":"Pediatrics"},{"key":"2235_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fped.2020.00428","volume":"8","author":"M Czosnykowska-\u0141ukacka","year":"2020","unstructured":"Czosnykowska-\u0141ukacka M, Lis-Kuberka J, Kr\u00f3lak-Olejnik B, Orczyk-Pawi\u0142owicz M (2020) Changes in human milk immunoglobulin profile during prolonged lactation. Front Pediatr 8:428","journal-title":"Front Pediatr"},{"key":"2235_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15585\/mmwr.mm6938e1","volume":"69","author":"MJ Delahoy","year":"2020","unstructured":"Delahoy MJ (2020) Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19\u2014COVID-NET, 13 States, March 1\u2013August 22, 2020. MMWR Morb Mortal Wkly Rep 69:1347\u20131354","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2235_CR27","first-page":"80","volume":"1","author":"EC Dinleyici","year":"2021","unstructured":"Dinleyici EC (2021) COVID-19 vaccines in children and adolescents. Pediatrics 1:80\u201389","journal-title":"Pediatrics"},{"key":"2235_CR28","unstructured":"Drugs and Lactation Database (LactMed\u00ae) (2023) National Institute of Child Health and Human Development, Bethesda. COVID-19 vaccines. [cited 2023 Oct 5]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK565969\/"},{"key":"2235_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/cid\/ciw027","volume":"62","author":"CS Eberhardt","year":"2016","unstructured":"Eberhardt CS, Blanchard-Rohner G, Lema\u00eetre B, Boukrid M, Combescure C, Othenin-Girard V et al (2016) Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis 62:829\u201336","journal-title":"Clin Infect Dis"},{"key":"2235_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31557\/APJCP.2021.22.1.19","volume":"22","author":"P Fadavi","year":"2021","unstructured":"Fadavi P, Houshyari M, Kashi ASY, Jarrahi AM, Roshanmehr F, Broomand MA et al (2021) Review on the oncology practice in the midst of COVID-19 crisis: the challenges and solutions. Asian Pac J Cancer Prev APJCP 22:19","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"2235_CR31","doi-asserted-by":"publisher","first-page":"1264502","DOI":"10.3389\/fimmu.2023.1264502","volume":"14","author":"M Faiyazuddin","year":"2023","unstructured":"Faiyazuddin M, Sophia A, Ashique S, Gholap AD, Gowri S, Mohanto S et al (2023) Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review. Front Immunol 14:1264502","journal-title":"Front Immunol"},{"key":"2235_CR32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/14760584.2021.1986390","volume":"20","author":"R Falsaperla","year":"2021","unstructured":"Falsaperla R, Leone G, Familiari M, Ruggieri M (2021) COVID-19 vaccination in pregnant and lactating women: a systematic review. Expert Rev Vaccines 20:1619\u201328","journal-title":"Expert Rev Vaccines"},{"key":"2235_CR33","first-page":"100410","volume":"18","author":"G Favre","year":"2022","unstructured":"Favre G, Maisonneuve E, Pomar L, Winterfeld U, Daire C, Martinez De Tejada B et al (2022) COVID-19 mRNA vaccine in pregnancy: results of the Swiss COVI-PREG registry, an observational prospective cohort study. Lancet Reg Health 18:100410","journal-title":"Lancet Reg Health"},{"key":"2235_CR34","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","volume":"37","author":"RA Feldman","year":"2019","unstructured":"Feldman RA, Fuhr R, Smolenov I, Mick Ribeiro A, Panther L, Watson M et al (2019) mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Vaccine 37:3326\u201334","journal-title":"Vaccine"},{"issue":"15","key":"2235_CR35","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2022.4255","volume":"327","author":"DB Fell","year":"2022","unstructured":"Fell DB, Dhinsa T, Alton GD, T\u00f6r\u00f6k E, Dimanlig-Cruz S, Regan AK et al (2022) Association of COVID-19 vaccination in pregnancy with adverse peripartum outcomes. JAMA 327(15):1478\u20131487","journal-title":"JAMA"},{"key":"2235_CR36","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1016\/j.vaccine.2018.07.012","volume":"36","author":"KB Fortner","year":"2018","unstructured":"Fortner KB, Swamy GK, Broder KR, Jimenez-Truque N, Zhu Y, Moro PL et al (2018) Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. Vaccine 36:6354\u201360","journal-title":"Vaccine"},{"key":"2235_CR37","doi-asserted-by":"publisher","first-page":"38874","DOI":"10.1038\/srep38874","volume":"6","author":"C Fu","year":"2016","unstructured":"Fu C, Lu L, Wu H, Shaman J, Cao Y, Fang F et al (2016) Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies. Sci Rep 6:38874","journal-title":"Sci Rep"},{"key":"2235_CR38","doi-asserted-by":"crossref","unstructured":"Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O et al (2021) Longitudinal analysis reveals distinct antibody and memory B cell responses in SARS-CoV2 Na\u00efve and recovered individuals following mRNA vaccination. medRxiv","DOI":"10.1101\/2021.03.03.21252872"},{"key":"2235_CR39","unstructured":"GOV.UK (2021) [cited 2025 Jul 7]. Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020. Available from: https:\/\/www.gov.uk\/government\/publications\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020"},{"key":"2235_CR40","unstructured":"GOV.UK (2023) [cited 2025 Jul 7]. COVID-19 vaccination: women who are pregnant or breastfeeding. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-women-of-childbearing-age-currently-pregnant-planning-a-pregnancy-or-breastfeeding"},{"key":"2235_CR41","unstructured":"GOV.UK (2025a) [cited 2025 Jul 7]. The safety of COVID-19 vaccines when given in pregnancy. Available from: https:\/\/www.gov.uk\/government\/publications\/safety-of-covid-19-vaccines-when-given-in-pregnancy\/the-safety-of-covid-19-vaccines-when-given-in-pregnancy"},{"key":"2235_CR42","unstructured":"GOV.UK (2025b) [cited 2025 Jul 7]. COVID-19: the green book, chapter 14a. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-the-green-book-chapter-14a"},{"key":"2235_CR43","doi-asserted-by":"publisher","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","volume":"225","author":"KJ Gray","year":"2021","unstructured":"Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N et al (2021) Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study. Am J Obstet Gynecol 225:303.e1-303.e17","journal-title":"Am J Obstet Gynecol"},{"key":"2235_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/vaccines10020233","volume":"10","author":"MS Green","year":"2022","unstructured":"Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D (2022) Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. Vaccines 10:233","journal-title":"Vaccines"},{"key":"2235_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n4","author":"H Hare","year":"2021","unstructured":"Hare H, Womersley K (2021) Why were breastfeeding women in the UK denied the COVID-19 vaccine? BMJ. https:\/\/doi.org\/10.1136\/bmj.n4","journal-title":"BMJ"},{"key":"2235_CR46","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/cid\/ciac803","volume":"76","author":"PT Heath","year":"2023","unstructured":"Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F et al (2023) Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial. Clin Infect Dis 76:398\u2013407","journal-title":"Clin Infect Dis"},{"key":"2235_CR47","doi-asserted-by":"publisher","first-page":"100162","DOI":"10.1016\/j.ajogmf.2020.100162","volume":"2","author":"JS Hirshberg","year":"2020","unstructured":"Hirshberg JS, Stout MJ, Raghuraman N (2020) Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2:100162","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2235_CR48","unstructured":"HSE.ie (2025) [cited 2025 Jul 7]. COVID-19 Vaccine Information for Health Professionals. Available from: https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/covid19vaccineinfo4hps\/covid19vaccineinfo4hps.html"},{"key":"2235_CR49","doi-asserted-by":"publisher","first-page":"e2022059595","DOI":"10.1542\/peds.2022-059595","volume":"151","author":"ML Hudak","year":"2023","unstructured":"Hudak ML, Flannery DD, Barnette K, Getzlaff T, Gautam S, Dhudasia MB et al (2023) Maternal and newborn hospital outcomes of perinatal SARS-CoV-2 infection: a national registry. Pediatrics 151:e2022059595","journal-title":"Pediatrics"},{"key":"2235_CR50","unstructured":"Interim recommendations for use of the Pfizer\u2013BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing (2022) [cited 2025 Jul 7]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1"},{"key":"2235_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/vaccines9060663","volume":"9","author":"K Jakuszko","year":"2021","unstructured":"Jakuszko K, Ko\u015bcielska-Kasprzak K, \u017babi\u0144ska M, Bartoszek D, Pozna\u0144ski P, Rukasz D et al (2021) Immune response to vaccination against COVID-19 in breastfeeding health workers. Vaccines 9:663","journal-title":"Vaccines"},{"key":"2235_CR52","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4103\/singaporemedj.SMJ-2021-259","volume":"65","author":"PA Jayagobi","year":"2023","unstructured":"Jayagobi PA, Ong C, Yeo KT, Lim CCW, Seet MJ, Kwek LK et al (2023) Perceptions and acceptance of COVID-19 vaccine among pregnant and lactating women in Singapore: a pre-vaccine rollout cross-sectional study. Singapore Med J 65:494\u2013501","journal-title":"Singapore Med J"},{"key":"2235_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","volume":"178","author":"MF Jennewein","year":"2019","unstructured":"Jennewein MF, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette FJ, Krykbaeva M et al (2019) Fc glycan-mediated regulation of placental antibody transfer. Cell 178:202\u2013215","journal-title":"Cell"},{"key":"2235_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/ID9.0000000000000003","volume":"1","author":"HD Jiang","year":"2021","unstructured":"Jiang HD, Li JX, Zhang P, Huo X, Zhu FC (2021) The COVID-19 vaccine in clinical trials: where are we now? Infect Dis Immun 1:43\u201351","journal-title":"Infect Dis Immun"},{"key":"2235_CR55","unstructured":"Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination (2020) Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5ff5cde88fa8f53b772750d2\/jcvi-advice-on-priority-groups-for-covid-19-vaccination-30-dec-2020-revised.pdf"},{"key":"2235_CR56","unstructured":"JointESHRE_IFFSvaccination (2025) [cited 2025 Jul 7]. Available from: https:\/\/www.eshre.eu\/Europe\/Position-statements\/COVID19\/JointESHRE_IFFSvaccination"},{"key":"2235_CR57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/jpm13050797","volume":"13","author":"C Juli\u00e1-Burch\u00e9s","year":"2023","unstructured":"Juli\u00e1-Burch\u00e9s C, Mart\u00ednez-Varea A (2023) An update on COVID-19 vaccination and pregnancy. J Pers Med 13:797","journal-title":"J Pers Med"},{"key":"2235_CR58","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.15585\/mmwr.mm6932e3","volume":"69","author":"L Kim","year":"2020","unstructured":"Kim L, Whitaker M, O\u2019Halloran AC, Kambhampati AK, Chai SJ, Reingold AL et al (2020) Hospitalization rates and characteristics of children aged < 18 years hospitalized with laboratory-confirmed COVID-19 \u2014 COVID-NET, 14 states, March 1\u2013July 25, 2020. Morb Mortal Wkly Rep 69:1081\u20131088","journal-title":"Morb Mortal Wkly Rep"},{"key":"2235_CR59","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/j.vaccine.2019.04.075","volume":"37","author":"S Kochhar","year":"2019","unstructured":"Kochhar S, Edwards KM, Ropero Alvarez AM, Moro PL, Ortiz JR (2019) Introduction of new vaccines for immunization in pregnancy - programmatic, regulatory, safety and ethical considerations. Vaccine 37:3267\u201377","journal-title":"Vaccine"},{"key":"2235_CR60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.immuni.2017.03.009","volume":"46","author":"TR Kollmann","year":"2017","unstructured":"Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O (2017) Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity 46:350\u201363","journal-title":"Immunity"},{"key":"2235_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12978-021-01070-6","volume":"18","author":"B Kotlar","year":"2020","unstructured":"Kotlar B, Gerson E, Petrillo S, Langer AI, Tiemeier H (2020) The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reprod Health 18:10","journal-title":"Reprod Health"},{"issue":"7830","key":"2235_CR62","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586(7830):516\u201327","journal-title":"Nature"},{"key":"2235_CR63","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMc2101667","volume":"384","author":"F Krammer","year":"2021","unstructured":"Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF et al (2021) Antibody responses in seropositive persons after a single dose of COVID-19 mRNA vaccine. N Engl J Med 384:1372\u2013134","journal-title":"New Engl J Med"},{"key":"2235_CR64","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jiph.2021.04.005","volume":"14","author":"R Kumar","year":"2021","unstructured":"Kumar R, Yeni CM, Utami NA, Masand R, Asrani RK, Patel SK et al (2021) SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: concerns, challenges, management and mitigation strategies\u2013a narrative review. J Infect Public Health 14:863\u201375","journal-title":"J Infect Public Health"},{"key":"2235_CR65","first-page":"e38547","volume":"15","author":"U Kumari","year":"2023","unstructured":"Kumari U, Sharma RK, Sinha A, Sinha M, Keshari JR (2023) Impact of COVID-19 vaccination on women during pregnancy and breastfeeding. Cureus 15:e38547","journal-title":"Cureus"},{"key":"2235_CR66","doi-asserted-by":"publisher","first-page":"427696","DOI":"10.1155\/2013\/427696","volume":"2013","author":"YC Lee","year":"2013","unstructured":"Lee YC, Lin SJ (2013) Neonatal natural killer cell function: relevance to antiviral immune defense. Clin Dev Immunol 2013:427696","journal-title":"Clin Dev Immunol"},{"key":"2235_CR67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.eimc.2021.07.007","volume":"40","author":"MDR Le\u00f3n-Morillo","year":"2022","unstructured":"Le\u00f3n-Morillo MDR, Gomez-Pastrana D, D\u00edaz-Colom MC, Quecuty-Vela S, Alados-Arboledas JC, Arag\u00f3n-Fern\u00e1ndez C (2022) Effect of pertussis vaccine in pregnancy and COVID-19 pandemic in the cases of wooping cough. Enferm Infecc Microbiol Clin Engl Ed 40:499\u2013502","journal-title":"Enferm Infecc Microbiol Clin Engl Ed"},{"key":"2235_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13006-022-00465-w","volume":"17","author":"X Liu","year":"2022","unstructured":"Liu X, Chen H, An M, Yang W, Wen Y, Cai Z et al (2022) Recommendations for breastfeeding during Coronavirus Disease 2019 (COVID-19) pandemic. Int Breastfeed J 17:28","journal-title":"Int Breastfeed J"},{"key":"2235_CR69","doi-asserted-by":"publisher","first-page":"e079364","DOI":"10.1136\/bmj-2024-079364","volume":"17","author":"MC Magnus","year":"2024","unstructured":"Magnus MC, S\u00f6derling J, \u00d6rtqvist AK, Andersen AMN, Stephansson O, H\u00e5berg SE et al (2024) Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study. BMJ 17:e079364","journal-title":"BMJ"},{"key":"2235_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/pds.5600","volume":"32","author":"O Mansour","year":"2023","unstructured":"Mansour O, Hernandez\u2010Diaz S, Wyszynski DF (2023) mRNA COVID\u201019 vaccination early in pregnancy and the risk of spontaneous abortion in an international pregnancy registry. Pharmacoepidemiol Drug Saf 32:685\u201393","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2235_CR71","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","volume":"70","author":"S Mbaeyi","year":"2021","unstructured":"Mbaeyi S, Oliver SE, Collins JP, Godfrey M, Goswami ND, Hadler SC et al (2021) The Advisory Committee on Immunization Practices\u2019 interim recommendations for additional primary and booster doses of COVID-19 vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep 70:1545\u20131552","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2235_CR72","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ajog.2021.01.025","volume":"224","author":"H Minkoff","year":"2021","unstructured":"Minkoff H, Ecker J (2021) Balancing risks: making decisions for maternal treatment without data on fetal safety. Am J Obstet Gynecol 224:479\u201383","journal-title":"Am J Obstet Gynecol"},{"key":"2235_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","volume":"225","author":"LB Mithal","year":"2021","unstructured":"Mithal LB, Otero S, Shanes ED, Goldstein JA, Miller ES (2021) Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. Am J Obstet Gynecol 225:192\u2013194","journal-title":"Am J Obstet Gynecol"},{"key":"2235_CR74","doi-asserted-by":"publisher","first-page":"103805","DOI":"10.1016\/j.ebiom.2021.103805","volume":"75","author":"G Moncunill","year":"2022","unstructured":"Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmer\u00f3n G et al (2022) Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers. EBioMedicine 75:103805","journal-title":"EBioMedicine"},{"key":"2235_CR75","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.7861\/clinmed.2021-0503","volume":"21","author":"M Nana","year":"2021","unstructured":"Nana M, Nelson-Piercy C (2021) COVID-19 in pregnancy. Clin Med 21:e446-50","journal-title":"Clin Med"},{"key":"2235_CR76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148\u201358","journal-title":"Nat Rev Immunol"},{"key":"2235_CR77","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.3390\/ijms24032957","volume":"24","author":"V Nicolaidou","year":"2023","unstructured":"Nicolaidou V, Georgiou R, Christofidou M, Felekkis K, Pieri M, Papaneophytou C (2023) Detection of SARS-CoV-2\u2013specific antibodies in human breast milk and their neutralizing capacity after COVID-19 vaccination: a systematic review. Int J Mol Sci 24:2957","journal-title":"Int J Mol Sci"},{"key":"2235_CR78","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","volume":"5","author":"S Niewiesk","year":"2014","unstructured":"Niewiesk S (2014) Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 5:446","journal-title":"Front Immunol"},{"key":"2235_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/jpm13010040","volume":"13","author":"B Novillo","year":"2022","unstructured":"Novillo B, Mart\u00ednez-Varea A (2022) COVID-19 vaccines during pregnancy and breastfeeding: a systematic review. J Pers Med 13:40","journal-title":"J Pers Med"},{"key":"2235_CR80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.03192-20","volume":"12","author":"RM Pace","year":"2021","unstructured":"Pace RM, Williams JE, J\u00e4rvinen KM, Belfort MB, Pace CDW, Lackey KA et al (2021) Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19. Mbio 12:10","journal-title":"Mbio"},{"key":"2235_CR81","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.15585\/mmwr.mm6938e2","volume":"69","author":"L Panagiotakopoulos","year":"2020","unstructured":"Panagiotakopoulos L (2020) SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics\u2014eight US health care centers, March 1\u2013May 30, 2020. MMWR Morb Mortal Wkly Rep 69:1355","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2235_CR82","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3855\/jidc.12744","volume":"14","author":"SK Patel","year":"2020","unstructured":"Patel SK, Pathak M, Tiwari R, YatooMohdI MYS, Sah R et al (2020) A vaccine is not too far for COVID-19. J Infect Dev Ctries 14:450\u2013453","journal-title":"J Infect Dev Ctries"},{"key":"2235_CR83","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12887-021-02618-y","volume":"21","author":"G Paul","year":"2021","unstructured":"Paul G, Chad R (2021) Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination \u2013 a case report. BMC Pediatr 21:138","journal-title":"BMC Pediatr"},{"key":"2235_CR84","first-page":"100045","volume":"4","author":"S Peng","year":"2020","unstructured":"Peng S, Zhu H, Yang L, Cao L, Huang X, Dynes M et al (2020) A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. Lancet Reg Health West Pac 4:100045","journal-title":"Lancet Reg Health West Pac"},{"key":"2235_CR85","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1001\/jama.2021.5782","volume":"325","author":"SH Perl","year":"2021","unstructured":"Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E et al (2021) COVID-19-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA 325:2013\u20132014","journal-title":"JAMA"},{"key":"2235_CR86","unstructured":"Pfizer\/BioNTech (2021) Annex I: summary of product characteristics. [cited 2023 Feb 2]. Available from: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2020\/20201221150522\/anx_150522_en.pdf"},{"key":"2235_CR87","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1080\/21645515.2020.1825896","volume":"16","author":"AA Rabaan","year":"2020","unstructured":"Rabaan AA, Al-Ahmed SH, Sah R, Al-Tawfiq JA, Al-Qaaneh AM, Al-Jamea LH et al (2020) Recent advances in vaccine and immunotherapy for COVID-19. Hum Vaccines Immunother 16:3011\u20133022","journal-title":"Hum Vaccines Immunother"},{"key":"2235_CR88","doi-asserted-by":"publisher","first-page":"e2021052286","DOI":"10.1542\/peds.2021-052286","volume":"148","author":"DSR Ram\u00edrez","year":"2021","unstructured":"Ram\u00edrez DSR, P\u00e9rez MML, P\u00e9rez MC, Hern\u00e1ndez MS, Pulido SM, Villacampa LP et al (2021) SARS-CoV-2 antibodies in breast milk after vaccination. Pediatrics 148:e2021052286","journal-title":"Pediatrics"},{"key":"2235_CR89","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7326\/M21-0173","volume":"174","author":"LE Riley","year":"2021","unstructured":"Riley LE, Jamieson DJ (2021) Inclusion of pregnant and lactating persons in COVID-19 vaccination efforts. Ann Intern Med 174:701\u2013702","journal-title":"Ann Intern Med"},{"key":"2235_CR90","doi-asserted-by":"publisher","first-page":"999136","DOI":"10.3389\/fimmu.2022.999136","volume":"13","author":"R Rubio","year":"2022","unstructured":"Rubio R, Aguilar R, Bustamante M, Mu\u00f1oz \u00c9, V\u00e1zquez-Santiago M, Santano R et al (2022) Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile. Front Immunol 13:999136","journal-title":"Front Immunol"},{"key":"2235_CR91","doi-asserted-by":"publisher","first-page":"e04965","DOI":"10.1016\/j.heliyon.2020.e04965","volume":"6","author":"T Rume","year":"2020","unstructured":"Rume T, Islam S (2020) Environmental effects of COVID-19 pandemic and potential strategies of sustainability. Heliyon 6:e04965","journal-title":"Heliyon"},{"key":"2235_CR92","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S1473-3099(22)00426-1","volume":"22","author":"M Sadarangani","year":"2022","unstructured":"Sadarangani M, Soe P, Shulha HP, Valiquette L, Vanderkooi OG, Kellner JD et al (2022) Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis 22:1553\u201364","journal-title":"Lancet Infect Dis"},{"key":"2235_CR93","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00281-017-0654-9","volume":"39","author":"A Saso","year":"2017","unstructured":"Saso A, Kampmann B (2017) Vaccine responses in newborns. Semin Immunopathol 39:627\u2013642","journal-title":"Semin Immunopathol"},{"key":"2235_CR94","doi-asserted-by":"crossref","unstructured":"Scendoni R, Fedeli P, Cingolani M (2023) The state of play on COVID-19 vaccination in pregnant and breastfeeding women: recommendations, legal protection, ethical issues and controversies in Italy. In: Healthcare. MDPI, p 328","DOI":"10.3390\/healthcare11030328"},{"key":"2235_CR95","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.vaccine.2018.05.117","volume":"36","author":"EP Schlaudecker","year":"2018","unstructured":"Schlaudecker EP, Ambroggio L, McNeal MM, Finkelman FD, Way SS (2018) Declining responsiveness to influenza vaccination with progression of human pregnancy. Vaccine 36:4734\u20134741","journal-title":"Vaccine"},{"key":"2235_CR96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpobgyn.2021.03.007","volume":"76","author":"M Sebghati","year":"2021","unstructured":"Sebghati M, Khalil A (2021) Uptake of vaccination in pregnancy. Best Pract Res Clin Obstet Gynaecol 76:53\u201365","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2235_CR97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-022-01043-9","volume":"14","author":"M Selma-Royo","year":"2022","unstructured":"Selma-Royo M, B\u00e4uerl C, Mena-Tudela D, Aguilar-Camprub\u00ed L, P\u00e9rez-Cano FJ, Parra-Llorca A et al (2022) Anti-COVID-19 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous COVID-19 exposure: a longitudinal study. Genome Med 14:42","journal-title":"Genome Med"},{"key":"2235_CR98","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette A, Crotty S (2021) Adaptive immunity to COVID-19 and COVID-19. Cell 184:861\u2013880","journal-title":"Cell"},{"key":"2235_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12884-024-06329-x","volume":"24","author":"N Skhvitaridze","year":"2024","unstructured":"Skhvitaridze N, Gamkrelidze A, Manjavidze T, Brenn T, Rylander C (2024) SARS-CoV-2 infection during pregnancy and the risk of adverse maternal outcomes in the Republic of Georgia: a national birth registry-based cohort study. BMC Pregnancy Childbirth 24:156","journal-title":"BMC Pregnancy Childbirth"},{"key":"2235_CR100","unstructured":"SOGC Statement on COVID-19 Vaccination in Pregnancy (2025) [cited 2025 Jul 7]. Available from: https:\/\/sogc.org\/en\/en\/content\/featured-news\/SOGC_Statement_on_COVID-19_Vaccination_in_Pregnancy.aspx"},{"key":"2235_CR101","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2021.3645","volume":"325","author":"KE Stephenson","year":"2021","unstructured":"Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C et al (2021) Immunogenicity of the Ad26.COV2.S vaccine for COVID-19. JAMA 325:1535\u20131544","journal-title":"JAMA"},{"key":"2235_CR102","unstructured":"Strategic Advisory Group of Experts (SAGE) (2020) Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine. Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine. [cited 2023 Jan 22]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE-recommendation-Ad26.COV2.S-background-2021.1"},{"key":"2235_CR103","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2009316","volume":"382","author":"D Sutton","year":"2020","unstructured":"Sutton D, Fuchs K, D\u2019Alton M, Goffman D (2020) Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med 382:2163\u20132164","journal-title":"N Engl J Med"},{"key":"2235_CR104","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3389\/fimmu.2019.02729","volume":"10","author":"NG Than","year":"2019","unstructured":"Than NG, Hahn S, Rossi SW, Szekeres-Bartho J (2019) Editorial: fetal-maternal immune interactions in pregnancy. Front Immunol 10:2729","journal-title":"Front Immunol"},{"key":"2235_CR105","unstructured":"The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know (2022) [cited 2025 Jul 7]. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know"},{"key":"2235_CR106","unstructured":"The Oxford\/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know (2022) [cited 2025 Jul 7]. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know"},{"key":"2235_CR107","unstructured":"The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: what you need to know (2022) [cited 2025 Jul 7]. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know"},{"key":"2235_CR108","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/1471-0528.17354","volume":"130","author":"M Tormen","year":"2023","unstructured":"Tormen M, Taliento C, Salvioli S, Piccolotti I, Scutiero G, Cappadona R et al (2023) Effectiveness and safety of COVID-19 vaccine in pregnant women: a systematic review with meta-analysis. BJOG Int J Obstet Gynaecol 130:348\u201357","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2235_CR109","unstructured":"United States Food and Drug Administration (US FDA) (2020) Moderna COVID-19 vaccine. Vaccines and related biological products advisory committee briefing document. [cited 2023 Jan 21]. Available from: https:\/\/www.fda.gov\/media\/144434\/download"},{"key":"2235_CR110","unstructured":"United States Food and Drug Administration (US FDA) (2022) Meeting of the oncologic drugs advisory committee meeting announcement - 02\/10\/2022. [cited 2023 Feb 3]. Available from: https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/february-10-2022-meeting-oncologic-drugs-advisory-committee-meeting-announcement-02102022"},{"key":"2235_CR111","doi-asserted-by":"crossref","unstructured":"van Keulen BJ, Romijn M, Bondt A, Dingess KA, Kontopodi E, van der Straten K et al (2020) Breastmilk; a source of SARS-CoV-2 specific IgA antibodies. medRxiv. 2020-08","DOI":"10.1101\/2020.08.18.20176743"},{"key":"2235_CR112","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","volume":"383","author":"EE Walsh","year":"2020","unstructured":"Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA (2020) Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 383:2439","journal-title":"N Engl J Med"},{"issue":"7855","key":"2235_CR113","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S et al (2021) mRNA vaccine-elicited antibodies to COVID-19 and circulating variants. Nature 592(7855):616\u201322","journal-title":"Nature"},{"key":"2235_CR114","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s11606-021-06698-5","volume":"26","author":"M Webb Hooper","year":"2021","unstructured":"Webb Hooper M, N\u00e1poles AM, P\u00e9rez-Stable EJ (2021) No populations left behind: vaccine hesitancy and equitable diffusion of effective COVID-19 vaccines. J Gen Intern Med 26:2130\u20132133","journal-title":"J Gen Intern Med"},{"key":"2235_CR115","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","volume":"193","author":"SQ Wei","year":"2021","unstructured":"Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N (2021) The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 193:E540\u2013E48","journal-title":"CMAJ"},{"key":"2235_CR116","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","volume":"8","author":"CR Wilcox","year":"2017","unstructured":"Wilcox CR, Holder B, Jones CE (2017) Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy. Front Immunol 8:1294","journal-title":"Front Immunol"},{"key":"2235_CR117","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.micpath.2025.107398","volume":"20","author":"S Yasmin","year":"2025","unstructured":"Yasmin S, Ansari MY (2025) A detailed examination of coronavirus disease 2019 (COVID-19): covering past and future perspectives. Microb Pathog 20:107398","journal-title":"Microb Pathog"},{"issue":"265","key":"2235_CR118","doi-asserted-by":"publisher","first-page":"130754","DOI":"10.1016\/j.ijbiomac.2024.130754","volume":"1","author":"S Yasmin","year":"2024","unstructured":"Yasmin S, Ansari MY, Pandey K, Dikhit MR (2024) Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach. Int J Biol Macromol 1(265):130754","journal-title":"Int J Biol Macromol"},{"key":"2235_CR119","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3389\/fimmu.2018.01759","volume":"9","author":"JC Yu","year":"2018","unstructured":"Yu JC, Khodadadi H, Malik A, Davidson B, Salles \u00c9D, Bhatia J et al (2018) Innate immunity of neonates and infants. Front Immunol 9:1759","journal-title":"Front Immunol"},{"key":"2235_CR120","doi-asserted-by":"publisher","first-page":"E312","DOI":"10.1503\/cmaj.202833","volume":"193","author":"JS Zipursky","year":"2021","unstructured":"Zipursky JS, Greenberg RA, Maxwell C, Bogler T (2021) Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: an ethics-based framework for shared decision-making. CMAJ 193:E312\u2013E314","journal-title":"CMAJ"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02235-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:02:38Z","timestamp":1778860958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02235-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}